Consumers seeking advanced healthcare options in India’s North and East can look forward to better facilities as Global Health Limited (NSE: Medanta, BSE: 543654) announced its highest-ever first-quarter results for FY26. Total income rose 19.1% year-on-year to ₹10,513 million, EBITDA grew 22.6% to ₹2,553 million, and Profit After Tax surged 49.6% to ₹1,590 million.
For patients, this growth translates to expanding services and improved care. Occupied bed days rose 13.3%, ARPOB increased to ₹66,584, and in-patient and out-patient volumes saw double-digit growth. Mature hospitals earned ₹7,006 million in revenue, while developing hospitals surged 35.9% to ₹3,219 million. International patient revenue rose 33.8% to ₹636 million, and OPD pharmacy sales jumped 21.6%.
Medanta’s planned Northeast expansion could be a game changer. Currently, many residents travel long distances to Guwahati or Kolkata for specialized treatment, incurring high travel and stay costs. A Medanta presence in the region would offer easier access to quality care, reduce delays in treatment, and bring world-class medical services closer to home. CEO Pankaj Sahni said the strong quarter was powered by patient trust, capacity expansion in Ranchi, and the upcoming 550-bed Noida hospital, part of Medanta’s long-term growth strategy.
